Lysophosphatidylcholine induces glial cell activation: Role of rho kinase

GLIA

Volumn 57, Issue 8, 2009, Pages 898-907

  Sheikh, Abdullan Md ^a   Nagai, Atsushi ^a   Ryu, Jae K ^b   McLarnon, James G ^b   Kim, Seung U ^b   Masuda, Junichi ^a  

^a SHIMANE UNIVERSITY   (Japan)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Astrocytes; Cytokine; Microglia; Neurodegeneration; Neuroinflammation

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CYCLOOXYGENASE 2; FASUDIL; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR G2A; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATE BUFFERED SALINE; RHO KINASE; UNCLASSIFIED DRUG; AMIDE; ENZYME INHIBITOR; PTGS2 PROTEIN, HUMAN; PYRIDINE DERIVATIVE; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CELL ACTIVATION; CELL COUNT; CELL LOSS; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CHEMOTAXIS; CONTROLLED STUDY; CORPUS STRIATUM; EMBRYO; ENZYME INHIBITION; FETUS; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE SILENCING; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROGLIA; NERVE CELL CULTURE; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; TIME; ANIMAL; BRAIN; CELL CULTURE; CELL MOTION; CYTOLOGY; DRUG EFFECT; ENZYME ACTIVATION; GENETICS; GLIA; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

AMIDES; ANIMALS; BRAIN; CELL MOVEMENT; CELLS, CULTURED; CYCLOOXYGENASE 2; ENZYME ACTIVATION; ENZYME INHIBITORS; FETUS; GENE EXPRESSION REGULATION; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-1BETA; LYSOPHOSPHATIDYLCHOLINES; MALE; NEUROGLIA; NITRIC OXIDE SYNTHASE TYPE II; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RHO-ASSOCIATED KINASES; RNA, SMALL INTERFERING; TIME FACTORS;

EID: 67649948188     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20815     Document Type: Article

References (44)

1. Andreoli VM, Maffei F, Tonon GC, Zibetti A. 1973. Significance of plasma lysolecithin in patients with multiple sclerosis: A longitudinal study. J Neurol Neurosurg Psychiatry 36:661-667.
2. Ashida N, Arai H, Yamasaki M, Kita T. 2001. Distinct signaling pathways for MCP-1-dependent integrin activation and chemotaxis. J Biol Chem 276:16555-16560.
3. Bourguignon LY, Zhu H, Shao L, Zhu D, Chen YW. 1999. Rho-kinase (ROK) promotes CD44v(3, 8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells. Cell Motil Cytoskeleton 43:269-287.
4. Brown GC, Bal-Price A. 2003. Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27:325-355.
5. Chao CC, Lokensgard JR, Sheng WS, Hu S, Peterson PK. 1997. IL-1-induced iNOS expression in human astrocytes via NF-kappa B. Neuroreport 8:3163-3166.
6. Cieslik K, Zembowicz A, Tang JL, Wu KK. 1998. Transcriptional regulation of endothelial nitric-oxide synthase by lysophosphatidylcholine. J Biol Chem 273:14885-14890.
7. Cross AK, Woodroofe MN. 1999. Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro. J Neurosci Res 55:17-23.
8. Ding M, Pierre BA, Parkinson JF, Medberry P, Wong JL, Rogers NE, Ignarro LJ, Merrill JE. 1997. Inducible nitric-oxide synthase and nitric oxide production in human fetal astrocytes and microglia. J Biol Chem 272:11327-11335.
9. Farooqui AA, Ong WY, Horrocks LA. 2006. Inhibitors of brain phospholipase A2 activity: Their neuropharmacological effects and therapeutic importance for the treatment of neurologic disorders. Pharmacol Rev 58:591-620.
10. Galle J, Mameghani A, Bolz SS, Gambaryan S, Gorg M, Quaschning T, Raff U, Barth H, Seibold S, Wanner C, Pohl U. 2003. Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA. J Am Soc Nephrol 14:1471-1479.
11. Hatori K, Nagai A, Heisel R, Ryu JK, Kim SU. 2002. Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 69:418-426.
12. Holtsberg FW, Steiner MR, Keller JN, Mark RJ, Mattson MP, Steiner SM. 1998. Lysophosphatidic acid induces necrosis and apoptosis in hippocampal neurons. J Neurochem 70:66-76.
13. Huang F, Subbaiah PV, Holian O, Zhang J, Johnson A, Gertzberg N, Lum H. 2005. Lysophosphatidylcholine increases endothelial permeability: Role of PKCalpha and RhoA cross talk. Am J Physiol Lung Cell Mol Physiol 289:L176-L185.
14. Kabarowski JH, Zhu K, Le LQ, Witte ON, Xu Y. 2001. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293:702-705.
15. Kinouchi H, Imaizumi S, Yoshimoto T, Yamamoto H, Motomiya M. 1990. Changes of polyphosphoinositides, lysophospholipid, and free fatty acids in transient cerebral ischemia of rat brain. Mol Chem Neuropathol 12:215-228.
16. Kitamura Y, Matsuoka Y, Nomura Y, Taniguchi T. 1998. Induction of inducible nitric oxide synthase and heme oxygenase-1 in rat glial cells. Life Sci 62:1717-1721.
17. Klivenyi P, Beal MF, Ferrante RJ, Andreassen OA, Wermer M, Chin MR, Bonventre JV. 1998. Mice deficient in group IV cytosolic phospholipase A2 are resistant to MPTP neurotoxicity. J Neurochem 71:2634-2637.
18. Kume N, Cybulsky MI, Gimbrone MA Jr. 1992. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 90:1138-1144.
19. Kume N, Gimbrone MA Jr. 1994. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 93:907-911.
20. Le LQ, Kabarowski JH, Weng Z, Satterthwaite AB, Harvill ET, Jensen ER, Miller JF, Witte ON. 2001. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity 14:561-571.
21. Lee ES, Chen H, Shepherd KR, Lamango NS, Soliman KF, Charlton CG. 2004. Inhibitory effects of lysophosphatidylcholine on the dopaminergic system. Neurochem Res 29:1333-1342.
22. Matsumoto Y, Uwatoku T, Oi K, Abe K, Hattori T, Morishige K, Eto Y, Fukumoto Y, Nakamura K, Shibata Y, Matsuda T, Takeshita A, Shimokawa H. 2004. Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: Involvement of multiple mechanisms. Arterioscler Thromb Vasc Biol 24:181-186.
23. Minghetti L. 2005. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 18:315-321.
24. Morimoto M, Kume N, Miyamoto S, Ueno Y, Kataoka H, Minami M, Hayashida K, Hashimoto N, Kita T. 2001. Lysophosphatidylcholine induces early growth response factor-1 expression and activates the core promoter of PDGF-A chain in vascular endothelial cells. Arterioscler Thromb Vasc Biol 21:771-776.
25. Nagai A, Nakagawa E, Hatori K, Choi HB, McLarnon JG, Lee MA, Kim SU. 2001. Generation and characterization of immortalized human microglial cell lines: Expression of cytokines and chemokines. Neurobiol Dis 8:1057-1068.
26. Nishi E, Kume N, Ueno Y, Ochi H, Moriwaki H, Kita T. 1998. Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes. Circ Res 83:508-515.
27. Ochi H, Kume N, Nishi E, Kita T. 1995. Elevated levels of cAMP inhibit protein kinase C-independent mechanisms of endothelial platelet-derived growth factor-B chain and intercellular adhesion molecule-1 gene induction by lysophosphatidylcholine. Circ Res 77:530-535.
28. Oka H, Kugiyama K, Doi H, Matsumura T, Shibata H, Miles LA, Sugiyama S, Yasue H. 2000. Lysophosphatidylcholine induces urokinase-type plasminogen activator and its receptor in human macrophages partly through redox-sensitive pathway. Arterioscler Thromb Vasc Biol 20:244-50.
29. Ousman SS, David S. 2000. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 30:92-104.
30. Ousman SS, David S. 2001. MIP-1α, MCP-1, GM-CSF, and TNFα control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 21:4649-4656.
31. Paxinos G, Watson C. 1982. The rat brain in stereotaxic coordinates. New York: Academic Press.
32. Radu CG, Yang LV, Riedinger M, Au M, Witte ON. 2004. T cell chemotaxis to lysophosphatidylcholine through the G2A receptor. Proc Natl Acad Sci USA 101:245-250.
33. Rikitake Y, Hirata K, Yamashita T, Iwai K, Kobayashi S, Itoh H, Ozaki M, Ejiri J, Shiomi M, Inoue N, Kawashima S, Yokoyama M. 2002. Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 22:2049-2053.
34. Sakata-Kaneko S, Wakatsuki Y, Usui T, Matsunaga Y, Itoh T, Nishi E, Kume N, Kita T. 1998. Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human CD41 T cells. FEBS Lett 433:161-165.
35. Schilling T, Lehmann F, Ruckert B, Eder C. 2004. Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia. J Physiol 557(Part 1):105-120.
36. Sheikh AM, Ochi H, Manabe A, Masuda J. 2005. Lysophosphatidylcholine posttranscriptionally inhibits interferon-gamma-induced IP-10, Mig and I-Tac expression in endothelial cells. Cardiovasc Res 65:263-271.
37. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81:3883-3887.
38. Suzumura A, Takeuchi H, Zhang G, Kuno R, Mizuno T. 2006. Roles of glia-derived cytokines on neuronal degeneration and regeneration. Ann N Y Acad Sci 1088:219-229.
39. Takenouchi T, Iwamaru Y, Sugama S, Sato M, Hashimoto M, Kitani H. 2008. Lysophospholipids and ATP mutually supress maturation and release of IL-1β in mouse microglial cells using a Rho-dependent pathway. J Immunol 180:7827-7839.
40. Takenouchi T, Sato M, Kitani H. 2007. Lysophosphatidylcholine potentiates Ca2+ influx, pore formation and p44/42 MAP kinase phosphorylation mediated by P2X7 receptor activation in mouse microglial cells. J Neurochem 102:1518-1532.
41. Umezu-Goto M, Kishi Y, Taira A, Hama K, Dohmae N, Taiko K, Yamori T, Mills GB, Inoue K, Aoki J, Arai H. 2002. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production. J Cell Biol 158:227-233.
42. Wender M, Adamczewska-Goncerzewicz Z, Szczech J, Godlewski A. 1988. Myelin lipids in aging human brain. Neurochem Pathol 8:121-130.
43. Zhu K, Baudhuin LM, Hong G, Williams FS, Cristina KL, Kabarowski JH, Whitte ON, Xu Y. 2001. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J Biol Chem 276:41325-41335.
44. Zumwalt JW, Thunstrom BJ, Spangelo BL. 1999. Interleukin-1β and catecholamines synergistically stimulate interleukin-6 release from rat C6 glioma cells in vitro: A potential role for lysophosphatidylcholine. Endocrinology 140:888-896.